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Brief reports
Abstract: Rhinoscleroma is a chronic granulomatous infectious disease 
that is rare in Western Europe. We report the case of a 5-year-old Portuguese 
boy diagnosed with rhinoscleroma in the context of recurrent epistaxis. He 
had a 6-month course of antibiotic (amoxicillin plus clavulanate) therapy 
with full recovery.  
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Rhinoscleroma is a chronic granulomatous infectious disease of the upper respiratory tract caused by the Gram-negative coc-
cobacillus Klebsiella rhinoscleromatis, a subspecies of Klebsiella 
pneumoniae.1,2 Despite being broadly distributed in nature, it has 
not been found in a nonhuman host.2 It is endemic in some regions 
of Africa (Egypt, tropical areas), Southeast Asia, Mexico, Central 
and South America and Central and Eastern Europe. Although first 
reported in Europe, nowadays only a few sporadic cases have been 
described in Western Europe, probably the result of emigration of 
people from endemic areas.1
Rhinoscleroma can affect most parts of the respiratory 
tract and is classified in 3 overlapping stages: catarrhal or atrophic 
(sometimes called ozaena), granulomatous (proliferative or nodu-
lar) and sclerotic (cicatricial or fibrotic).3 Most patients are diag-
nosed in the granulomatous stage, in which the typical histologic 
characteristics can be observed.3 Culture of biopsy specimens is 
the most useful diagnostic test to distinguish it from other granu-
lomatous diseases with identical histologic characteristics, but 
culture is positive only in half the patients during the granuloma-
tous stage.234
Treatment includes long-term antibiotics and surgery in 
patients with obstructive symptoms.14,5 We report the case of rhi-
noscleroma in a 5-year-old previously healthy Portuguese boy, who 
responded completely to treatment with amoxicillin-clavulanate.
CASE REPORT
A 5-year-old Portuguese boy, the second child of a 
 non-consanguineous couple (Fig. 1A) was brought to the Emer-
gency Department with epistaxis for the 2 previous weeks with no 
other accompanying signs or symptoms. The child and his family 
had gone on vacation to the Dominican Republic the year before. 
The medical histories of his 10-year-old sister and parents were une-
ventful. Rhinoscopy revealed an intranasal bleeding mass (Fig. 1B) 
and magnetic resonance imaging confirmed the intranasal mass with 
extension to the bone of the ethmoid sinus (Fig. 1C). Histopathol-
ogy revealed chronic inflammation, granulomas and Mikulicz cells 
(large vacuolated histiocytes) with numerous intracellular Gram-
negative bacilli (Fig. 1D). Cultures of biopsy samples in MacCo-
nkey agar were positive for K. rhinoscleromatis that was susceptible 
to amoxicillin-clavulanate. Screening tests for immunodeficiency 
(immunoglobulins, lymphocyte subpopulations, phagocytosis test, 
oxidative burst and CH100) were normal. Genetic studies were neg-
ative for the DQA1*03011-DQB1*0301 haplotype.
He was treated with amoxicillin plus clavulanate (4:1) 
50 mg/kg/d, every 8 hours per os, for 6 months. Within a month, 
his symptoms resolved and the intranasal mass was significantly 
reduced. There was progressive reduction and eventual total disap-
pearance of macro and microscopic lesions when therapy had been 
given for 6 months. After 3 years of follow up, he remains asymp-
tomatic and rhinoscopy was normal (Fig. 1E).
DISCUSSION
K. rhinoscleromatis is transmitted by direct inhalation of 
droplets.3 Person-to-person transmission probably occurs by air-
borne secretions, but other risk factors such as overcrowded living 
facilities, poor hygiene and poor nutrition may be necessary for the 
disease to develop.2,5 In the current case, none of these conditions 
was verified. The only relevant history was a trip to the Dominican 
Republic, an endemic region.
A Mexican study showed that DQA1*03011-DQB1*0301 
haplotype is also a risk factor for developing Rhinoscleroma.6 Our 
patient’s genetic study was negative. Impaired cellular immunity 
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FIGURE 1.  A) Pedigree of the family. Squares, male subjects; 
circles,  female  subjects;  closed  symbols,  index  case;  open 
symbols, unaffected individuals. B) First rhinoscopy: middle 
turbinate and meatus mass. C) Coronal magnetic resonance 
imaging scan (T2-weighted): intranasal mass with extension 
to the ethmoid bone sinus. D) Histopathologic characteristic 
features  (granulomas containing Mikulicz  cells).  E)  Last  rhi-
noscopy: middle turbinate and meatus without lesions.
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with low CD4+ lymphocyte count and high CD8+ lymphocyte 
count and with decreased CD4/CD8 ratio within the lesion, pos-
sibly inducing a diminished or altered T-cell response, may be 
responsible for an increased host susceptibility to the development 
of rhinoscleroma.5 Humoral immune response itself does not con-
trol the infection, due to not only the bacterial intracellular nature 
and thick mucin coat but also the nonspecific nature of the host’s 
antibody response.5 In the present case, screening tests for immu-
nodeficiency were normal.
Rhinoscleroma can affect most parts of the respiratory tract.7 
Infection usually starts in the subepithelium of the nasal mucosa, 
with permanent damage in most cases, spreading thereafter to other 
areas.7 Eventually, subepithelial invasion by neutrophils and histio-
cytes can extend to the interstitium as well as to the adjacent carti-
lage and bone.7 In our patient, the mass was limited to the intranasal 
cavity and the bone lining of the ethmoid sinus.
Rhinoscleroma is classified in 3 overlapping stages described 
earlier.3 As observed in this case, most patients are diagnosed in the 
granulomatous stage, because this is the most symptomatic phase 
and exhibits characteristic histologic features (Mikulicz cell—large 
phagocytes with a single shrunken nucleus, displaced to the cell 
periphery because of the presence of multibacillary cytoplasmatic 
vacuoles; transformed plasma cells with Russell bodies; chronic 
inflammatory cells and pseudoepitheliomatous hyperplasia).8 Our 
patient, as described in literature, culture of biopsy specimens in 
MacConkey agar confirmed the diagnosis.3
Treatment includes surgery in patients with obstructive 
symptoms and long-term antimicrobial therapy in an attempt to 
eradicate K. rhinoscleromatis, because the relapse rate is high.1,3 
In vitro, these bacteria are inhibited by clinically achievable 
concentrations of amoxicillin-clavulanate, chloramphenicol, 
 trimethoprim-sulfamethoxazole, cephalosporins, streptomycin, 
tetracyclines and ciprofloxacin.3 However, in vivo, effective anti-
biotics are streptomycin, doxycycline, tetracycline, rifampicin, 
sulfonamides, clofazimine, ciprofloxacin and ofloxacin..2,3 
Because of our patient’s age, antibiotic choice was challenging, 
as most of the recommended drugs present risk of serious side 
effects in this age group. We decided to initiate a prolonged course 
(6 months) of amoxicillin plus clavulanate (4:1). The choice was 
based on the following criteria: broad spectrum of bactericidal 
activity against many Gram-positive and Gram-negative micro-
organisms (including Klebsiella species); favorable side effect 
profile; availability of a pediatric formulation and good compli-
ance in the long term.9 At present, after 3 years of follow up off 
antibiotherapy, the child remains asymptomatic and rhinoscler-
oma has clinically resolved. Several studies report relapses after 
initial clinical response.10 For this reason, our patient remains 
under annual follow up.
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SECONDARY BACTEREMIA IN ROTAVIRUS 
GASTROENTERITIS
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Abstract: The aim of the study was to determine the frequency of second-
ary bacteremia in children with rotavirus gastroenteritis and persistence or 
reemergence of fever. We identified 376 children with a mean of age of 
14.2 ± 10.1 months. A significant pathogen was isolated from blood cultures 
in 5 patients [Enterococcus faecium (n = 1), Klebsiella spp (n = 1), Staphy-
lococcus aureus (n = 1), Raoultella planticola (n = 1), Candida albicans 
(n = 1); 1.3%]. The frequency of secondary bacteremia in children with 
rotavirus gastroenteritis is low, but it should be considered when there is 
fever lasting >48 hours or reemergence of fever.  
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Acute diarrheal diseases cause 25–30% of all deaths among chil-dren <5 years in developing countries.1 Rotavirus is one of the 
most important causative agents of acute gastroenteritis in children 
between 4 and 24 months of life. Rotavirus gastroenteritis has an 
annual incidence of 130 million cases and 440,000 deaths and is 
responsible for approximately 20% of diarrhea-associated deaths in 
children <5 years of age.2,3 Although the pathogenesis of rotavirus 
infection is not fully understood, the main mechanisms are sug-
gested to be infiltration of mature enterocytes in the mid and upper 
part of the villi of the small intestine and alteration of the function 
of the small intestinal epithelium, resulting in malabsorptive diar-
rhea secondary to enterocyte destruction.4
The disease caused by rotavirus is usually self-limited in 
otherwise healthy infants. In addition to the noninfectious compli-
cations, secondary bacteremia complicating rotavirus gastroenteri-
tis has been reported in case reports. The aim of this study was to 
determine the frequency of secondary bacteremia in children with 
rotavirus gastroenteritis and persistence or reemergence of fever.
MATERIALS AND METHODS
This is a retrospective and descriptive study. Five-hundred 
and forty-two subjects with rotavirus gastroenteritis admitted 
to Behçet Uz Children’s Hospital between 2008 and 2012 were 
enrolled in this study. Demographic data and results of blood 
cultures were collected from the charts of the patients. Axillary 
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